Proton pump inhibitors: More indigestion than relief?
P Malavade, S Hiremath
Department of Nephrology, Narayana Hrudayalaya, Whitefield, Bengaluru, Karnataka, India; Department of Medicine, Division of Nephrology, The Ottawa Hospital, Ottawa, Canada
C/O, Vijaykumar Malavde, “Anugraha” Dhundshi Nagar, Sirsi - 581 401, Karnataka, India
Proton pump inhibitors (PPIs) are widely prescribed to treat a number of gastrointestinal (GI) disorders due to excessive acid production. While effective and safe, adverse renal effects have been increasingly described in epidemiological literature. The most well-documented adverse renal outcome is acute interstitial nephritis; however, association with overall acute kidney injury has also been recently reported. Recently, two observational studies have linked PPI use with chronic kidney disease. Finally, hypomagnesemia is another reported complication and is thought to be resulting from GI loss of magnesium. This study will critically review literature on the effect of PPIs on the kidney.
|How to cite this article:|
Malavade P, Hiremath S. Proton pump inhibitors: More indigestion than relief?.Indian J Nephrol 2017;27:249-257
|How to cite this URL:|
Malavade P, Hiremath S. Proton pump inhibitors: More indigestion than relief?. Indian J Nephrol [serial online] 2017 [cited 2022 Jul 3 ];27:249-257
Available from: https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2017;volume=27;issue=4;spage=249;epage=257;aulast=Malavade;type=0